Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.

Golnaz RoshankarGeneva C WhiteSebastien CadetNowell M FineDenise ChanJames A WhiteVictor Jimenez-ZepedaPiotr J SlomkaRobert J H Miller

Published in: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology (2021)

CPA and VOI were correlated with CMR measures of myocardial fibrosis in patients with ATTR-CM. 99mTc-pyrophosphate quantitation may have a role in ATTR-CM disease staging, guiding treatment, or following response to therapy.

Keyphrases

magnetic resonance
left ventricular
ms ms
mass spectrometry
lymph node
high resolution
liquid chromatography tandem mass spectrometry
computed tomography
stem cells
contrast enhanced
magnetic resonance imaging
bone marrow
high performance liquid chromatography
replacement therapy
atrial fibrillation